Jun. 25 at 2:48 PM
$ICCC doubling position.
The results of pivoting to contract manufacturing is making them very profitable after years of failing to get FDA approval for their in house production.
So what on earth is wrong with CEO retiring? And retiring now that company is making a good profit? New CEO would only join to build on. We shall, added @ just under
$6.00
"“I turn 65 this fall and have told my fellow Directors that I would like to retire from full-time work by early 2026,” said Michael F. Brigham, President and CEO. “I originally joined ImmuCell in 1989 and am very grateful to have had the opportunity to serve as the President and CEO of this growing Company since 2000.”